Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma
Open accessThe DOI matches its Crossref record; 152 of the 158 references it cites were found in a registry or an index; 92 of the 144 sources its claims cite were checked for support.
Abstract
Malignant pleural mesothelioma (MPM) is a lethal and rare cancer, even if its incidence has continuously increased all over the world. Asbestos exposure leads to the development of mesothelioma through multiple mechanisms, including chronic inflammation, oxidative stress with reactive oxygen species (ROS) generation, and persistent aberrant signaling. Together, these processes, over the years, force normal mesothelial cells’ transformation. Chronic inflammation supported by “frustrated” macrophages exposed to asbestos fibers is also boosted by the release of pro-inflammatory cytokines, chemokines, growth factors, damage-associated molecular proteins (DAMPs), and the generation of ROS. In addition, the hypoxic microenvironment influences MPM and immune cells’ features, leading to a significant rewiring of metabolism and phenotypic plasticity, thereby supporting tumor aggressiveness and modulating infiltrating immune cell responses. This review provides an overview of the complex tumor–host interactions within the MPM tumor microenvironment at different levels, i.e., soluble factors, metabolic crosstalk, and oxidative stress, and explains how these players supporting tumor transformation and progression may become potential and novel therapeutic targets in MPM.
Overview
CoChat Summary
TL;DR
This review synthesizes how chronic inflammation, oxidative stress/ROS, and metabolic plasticity jointly drive a pro-tumorigenic, immunosuppressive microenvironment in malignant pleural mesothelioma (MPM). It highlights candidate therapeutic targets including TGF-β, IL-6, TNF-α/HMGB1, redox-sensitive factors, the adenosine pathway, and BAP1-related metabolic reprogramming.
Key findings
- Asbestos-induced “frustrated phagocytosis” by macrophages causes ROS release, pro-inflammatory cytokines/chemokines (IL-8, IL-6, CCL2/MCP-1, G-CSF, GM-CSF, MIP-1α), DAMPs including HMGB1, and chronic inflammation that promotes mesothelial transformation; M2-like macrophages (CD163+, CD206+, IL-4Rα+) infiltrate MPM.
- TGF-β family members (gremlin-1, activin A, TGF-β) support MPM progression; TGF-β1 mRNA correlated with worst prognosis in 74 mesothelioma tumors. In a fresolimumab trial, no radiographic responses were observed, median progression time was 1.4 months, and 10 patients progressed after only two cycles. IL-6 is produced by mesothelioma cells, but its autocrine growth role is conflicting; it may mediate resistance to classic cytotoxic agents.
- Oxidative stress/ROS from asbestos iron content and inflammatory cells activates antioxidant pathways involving Nrf2, Ref-1, and FOXM1; a ROS–TGF-β1 axis promotes EMT, and iron/ferritin biology (FHC, FTL) plus ferroptosis resistance are implicated in asbestos-related carcinogenesis.
- Metabolic plasticity includes hypoxia-driven GLUT-1/HIF-1α/VEGF/PI3K-mTOR upregulation, LAT1-mediated amino acid deprivation of T cells, IDO-mediated tryptophan degradation, adenosine/CD39/CD73 signaling, and BAP1 loss shifting metabolism from TCA/OXPHOS toward aerobic glycolysis with increased extracellular lactate.
Methods
- Narrative review; no primary experiments, systematic search strategy, or meta-analysis are described. It synthesizes published literature on MPM tumor–host interactions, soluble factors, oxidative stress, and metabolic crosstalk.
- Evidence cited includes preclinical models, mesothelioma cell lines, patient pleural effusions/tumors, and clinical trials such as CheckMate 743 and a fresolimumab study. No sample size or literature-search details are stated.
Limitations
- The paper does not state a formal limitations section. Stated caveats include conflicting results on IL-6 as an autocrine growth factor, very little information about the adenosine pathway in MPM, and significant intra-tumoral and inter-tumoral heterogeneity between patients.
- Evident from the text: as a narrative review, it lacks systematic search and quality appraisal, and many mechanistic conclusions rely on heterogeneous preclinical or non-MPM findings; therapeutic targeting of these pathways remains largely speculative.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
61 Valid · 4 Not valid · 28 Not checked · 25 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Mechanistically, longer fibers cannot be effectively phagocytized by macrophages.”
§ Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma > 1. Introduction
What the sources say
- Supportedcites [18] Nagai, 2011, Asbestos Surface Provides a Niche for Oxidative Modification, Cancer Sci. source
The passage labeled Abstract states that long asbestos fibers, especially those over 15–20 μm, interrupt macrophage phagocytosis and prevent macrophages from clearing the fibers. This supports the citing sentence. (LLM, conf=0.94)
- Supportedcites [19] Gaudino, 2020, How Asbestos and Other Fibers Cause Mesothelioma, Transl. Lung Cancer Res. source
The section “Physicochemical features of the fibers govern their carcinogenic potential” states that longer fibers cannot be efficiently engulfed and cleared by macrophages, leading to failed attempts at phagocytosis. This directly supports the citing sentence’s paraphrase. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, chronic inflammation is the main factor underlying the pathogenesis of MPM induced by asbestos, leading to malignant mesothelial cell transformation.”
§ Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma > 1. Introduction
What the sources say
- Partly supportedcites [18] Nagai, 2011, Asbestos Surface Provides a Niche for Oxidative Modification, Cancer Sci. sourceExperimental — accuracy not yet measured
The Abstract (page not specified) links chronic inflammation to asbestos-induced genotoxicity in mesothelial cells and says an inflammatory cytokine might increase the likelihood of transformation. But it presents inflammation as one of several proposed mechanisms, alongside mesothelial cell injury, rather than establishing it as the main factor in MPM pathogenesis. (LLM, conf=0.86)
- Partly supportedcites [19] Gaudino, 2020, How Asbestos and Other Fibers Cause Mesothelioma, Transl. Lung Cancer Res. sourceExperimental — accuracy not yet measured
The ‘Chronic inflammation and mesothelioma’ section says chronic inflammation plays a major role in asbestos-induced pathogenesis and describes a pathway to mesothelial-cell transformation. It does not establish inflammation as the single main factor, rather than one major mechanism among others. (LLM, conf=0.83)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“TGF-β1 plays a crucial role in promoting EMT, a key process involved in modulating alveolar epithelial cell plasticity [87,88].”
§ Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma > 3. Mesothelioma Microenvironment: Tumor–Host Crosstalk Driving Chronic Inflammation > 3.2. Oxidative Stress and ROS
What the sources say
- Not checked — no full text of the sourcecites [87] Tamminen, 2012, Asbestos Exposure Induces Alveolar Epithelial Cell Plasticity through MAPK/Erk Signaling, J. Cell. Biochem. source
- Partly supportedcites [88] Tsubakihara, Y., and Moustakas, A. (2018). Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β. Int. J. Mol. Sci., 19. sourceExperimental — accuracy not yet measured
Section 2, “Regulation of EMT by TGF-β,” says TGF-β plays a prominent role in inducing EMT and specifies that its discussion includes TGF-β1. The Introduction describes EMT as a form of epithelial-cell plasticity, but the paper’s passages concern cancer and do not establish the claim specifically for alveolar epithelial cells. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“It has been described that extracellular ROS regulate the TGF-β axis [66,84,85].”
§ Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma > 3. Mesothelioma Microenvironment: Tumor–Host Crosstalk Driving Chronic Inflammation > 3.2. Oxidative Stress and ROS
What the sources say
- Supportedcites [66] Urso, 2020, Metabolic Rewiring and Redox Alterations in Malignant Pleural Mesothelioma, Br. J. Cancer source
The section “Effects of ROS on TGF-β in MPM” states that ROS in the extracellular space can activate TGF-β. It also describes an in vitro example in which ROS generated by asbestos-associated iron activated TGF-β1, supporting the attributed claim. (LLM, conf=0.94)
- Not matchedcites [84] Santibanez, 2015, Transforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer Progression, Oxid. Med. Cell. Longev.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [85] Jobling, 2006, Isoform-Specific Activation of Latent Transforming Growth Factor β (LTGF-β) by Reactive Oxygen Species, Radiat. Res. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As previously mentioned in this review, TGF-β itself and its family members have been recognized to be involved in cancer development [81], and TGF-β possesses a pro-oncogenic role in MPM connected to immune suppression [82,83].”
§ Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma > 3. Mesothelioma Microenvironment: Tumor–Host Crosstalk Driving Chronic Inflammation > 3.2. Oxidative Stress and ROS
What the sources say
- Not checked — no full text of the sourcecites [82] Suzuki, 2004, Soluble Type II Transforming Growth Factor-Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity, Clin. Cancer Res. source
- Partly supportedcites [83] Fujii, 2012, TGF-β Synergizes with Defects in the Hippo Pathway to Stimulate Human Malignant Mesothelioma Growth, J. Exp. Med. sourceExperimental — accuracy not yet measured
The Abstract reports pro-oncogenic effects of TGF-β signaling in malignant mesothelioma. The Discussion proposes that TGF-β produced by mesothelioma tumors might suppress immune responses in the surrounding environment, but does not establish immune suppression as the mechanism of its pro-oncogenic effect. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [81] Derynck, 2001, TGF-β Signaling in Tumor Suppression and Cancer Progression, Nat. Genet. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
65 more claims · 29 with their cited sources checked
Create a free account to see all 118 claims and every source verdict.
- It may state two separate claims as one. 46
- Probably not a substantial claim. 3
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“demonstrated that these redox-sensitive transcription factors that can counteract MPM chronic oxidative stress can therefore be considered as predictive biomarkers of MPM and potential pharmacological targets in the treatment of MPM [80].”
Cited work 10.3390/cancers13051138 · retracted 2021-03-07 · notice 10.3390/cancers18162564 · this paper published 2023-08-11
Citations
Cites
1 retracted
Schiavello, M., Gazzano, E., Bergandi, L., Silvagno, F., Libener, R., Riganti, C., & Aldieri, E. (2021) · Cancers · doi:10.3390/cancers13051138 · Cited by 8 · cited 1×
“demonstrated that these redox-sensitive transcription factors that can counteract MPM chronic oxidative stress can therefore be considered as predictive biomarkers of MPM and potential pharmacological targets in the treatment of MPM [80].”
BackgroundRetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 1×
“ROS, which are produced by cancer cells and non-cancer cells within the microenvironment, are essential elements connecting metabolic reprogramming/oxidative stress/inflamed environment, all of which are key aspects of cancer progression [70].”
BackgroundHallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887 · cited 5×
“In normal cells, most energy is derived via oxidative respiration (i.e., the tricarboxylic acid (TCA) cycle and oxidative phosphorylation (OXPHOS)).”
BackgroundInfluentialHow mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · cited 2×
“In turn, TGF-β can promote ROS production via the ETC [91] and downregulate the expression of antioxidant enzymes [84], suggesting a circuit of positive mutual regulation.”
BackgroundWhy Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744 · cited 5×
“In normal cells, most energy is derived via oxidative respiration (i.e., the tricarboxylic acid (TCA) cycle and oxidative phosphorylation (OXPHOS)).”
BackgroundInfluentialInflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806 · cited 1×
“Furthermore, another important kind of inflammation is therapy-induced inflammation, which progresses in response to various anti-neoplasm therapies, including radiotherapy, chemotherapy, and, recently, immunotherapies or biologic therapies, leading to a huge infiltration of immune cells [23].”
BackgroundROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis
D'Autréaux, B., & Toledano, M. B. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2256 · Cited by 3,642
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579 · cited 1×
“This axis could be pharmacologically targeted, opening up a possibility for novel combination therapy [92].”
BackgroundReactive oxygen species, cellular redox systems, and apoptosis
Circu, M. L., & Aw, T. Y. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.12.022 · Cited by 3,340 · cited 1×
“ROS are highly chemically reactive molecules, derived from the deficient reduction in molecular oxygen (O2) and playing a critical role as signaling molecules in tumorigenesis [68], including asbestos-mediated carcinogenesis [15,66,69].”
Background
Cited by
ROS: A “booster” for chronic inflammation and tumor metastasis
Chen, A., Huang, H., Fang, S., & Hang, Q. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189175 · Cited by 150
Oxidative Stress and Inflammation: Drivers of Tumorigenesis and Therapeutic Opportunities
Wang, M., Xiao, Y., Miao, J., Zhang, X., Liu, M., Zhu, L., Liu, H., Shen, X., Wang, J., Xie, B., et al. (2025) · Antioxidants · doi:10.3390/antiox14060735 · Cited by 124
Macrophages: Subtypes, Distribution, Polarization, Immunomodulatory Functions, and Therapeutics
Peng, M., Li, N., Wang, H., Li, Y., Liu, H., Luo, Y., Lang, B., Zhang, W., Li, S., Tian, L., et al. (2025) · MedComm · doi:10.1002/mco2.70304 · Cited by 122
“The CSF-1/IL-34–CSF-1R pathway is also related to chronic inflammation, oxidative stress, ROS generation, and sustained abnormal signal transduction [179]; thus, regulation of CSF-1R may hold promise for the treatment of chronic inflammatory diseases [180].”
Mesothelial and immune cells interplay in the tumor microenvironment
Sheng, R., Yin, Y., & Wang, X. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.03.014 · Cited by 19
Alkaptonuria: From Molecular Insights to a Dedicated Digital Platform
Milella, M. S., Geminiani, M., Trezza, A., Visibelli, A., Braconi, D., & Santucci, A. (2024) · Cells · doi:10.3390/cells13121072 · Cited by 16
“Oxidative Stress, Chronic Inflammation, and Secondary (AA) Amyloidosis in Rheumatic Diseases Oxidative stress and inflammation are common players in rheumatic diseases such as osteoarthritis (OA) [9,22,23] and rheumatoid arthritis (RA) [24–26].”
Background
Metadata
- Authors
- Fiorilla, I., Martinotti, S., Todesco, A. M., Bonsignore, G., Cavaletto, M., Patrone, M., Ranzato, E., & Audrito, V.
- Affiliations
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- Corresponding author
- Audrito, Valentina
- ORCID
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2023-08-11
- Volume
- 12
- Issue
- 16
- Pages
- 2048
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC10453755
- OpenAlex
- W4385759859
- Cited by
- 39
- References
- 158
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 10
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- the Associazione Italiana di Ricerca sul Cancro (MFAG-2021 #26004)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- malignant pleural mesothelioma, asbestos exposure, chronic inflammation, oxidative stress, reactive oxygen species, tumor microenvironment, metabolic plasticity, tumor hypoxia, tumor-associated macrophages, damage-associated molecular patterns, antitumor immunity, metabolic crosstalk, tumor progression, therapeutic target
- MeSH terms
- Mesothelioma, Malignant, Humans, Inflammation, Reactive Oxygen Species, Oxidative Stress, Tumor Microenvironment, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma. https://app.cochat.ai/papers/10.3390/cells12162048
- The paper
- Fiorilla, I., Martinotti, S., Todesco, A. M., Bonsignore, G., Cavaletto, M., Patrone, M., Ranzato, E., & Audrito, V. (2023). Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma. Cells. https://doi.org/10.3390/cells12162048
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.